BBP vs. IHE
Compare and contrast key facts about Virtus LifeSci Biotech Products ETF (BBP) and iShares U.S. Pharmaceuticals ETF (IHE).
BBP and IHE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. Both BBP and IHE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBP or IHE.
Correlation
The correlation between BBP and IHE is 0.63, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BBP vs. IHE - Performance Comparison
Key characteristics
BBP:
0.34
IHE:
0.37
BBP:
0.63
IHE:
0.61
BBP:
1.08
IHE:
1.08
BBP:
0.32
IHE:
0.39
BBP:
1.01
IHE:
1.25
BBP:
8.33%
IHE:
4.94%
BBP:
24.55%
IHE:
16.91%
BBP:
-44.32%
IHE:
-38.20%
BBP:
-16.64%
IHE:
-8.00%
Returns By Period
In the year-to-date period, BBP achieves a -5.35% return, which is significantly lower than IHE's 1.98% return. Over the past 10 years, BBP has outperformed IHE with an annualized return of 6.46%, while IHE has yielded a comparatively lower 3.07% annualized return.
BBP
-5.35%
-6.39%
-10.23%
9.11%
4.26%
6.46%
IHE
1.98%
-2.97%
-3.42%
7.20%
7.07%
3.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBP vs. IHE - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than IHE's 0.42% expense ratio.
Risk-Adjusted Performance
BBP vs. IHE — Risk-Adjusted Performance Rank
BBP
IHE
BBP vs. IHE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBP vs. IHE - Dividend Comparison
BBP has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.73%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 1.73% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% |
Drawdowns
BBP vs. IHE - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for BBP and IHE. For additional features, visit the drawdowns tool.
Volatility
BBP vs. IHE - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 14.01% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 11.80%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.